Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Login
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press/Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
Pharmacological Regulation of Dyslipoproteinaemia in Insulin Resistant States
Dick Chan
,
Gerald Watts
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacological Regulation of Dyslipoproteinaemia in Insulin Resistant States'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Lipoprotein
100%
Dyslipoproteinemia
100%
Receptor Blocking Agent
40%
Very Low Density Lipoprotein
40%
Endocannabinoid
40%
Dyslipidemia
40%
Non Insulin Dependent Diabetes Mellitus
40%
Cholesterol Ester Transfer Protein Inhibitor
20%
Fibric Acid Derivative
20%
Insulin Sensitizing Agent
20%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Stable Isotope
20%
Peroxisome Proliferator Activated Receptor Delta Agonist
20%
Rimonabant
20%
Insulin Resistance
20%
Fish Oil
20%
Cardiovascular Disease
20%
Apolipoprotein
20%